European Parliament

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
15 November 2013
E-013060-13
Question for written answer
to the Commission
Rule 117
Charles Tannock (ECR)

 Subject:  Safety of endocrine-disrupting chemicals (EDCs) found in toiletries, when used in combination
 Answer(s) 

Endocrine disruption can have wide-ranging effects, ranging from infertility to genital malformations in male foetuses. EU safety limits exist for individual chemicals such as the preservatives butylparaben and propylparaben, commonly found in toiletries, and ethylhexyl methoxycinnamate, a UV filter use in sun protection products. The World Health Organisation (WHO) has, however, recently expressed concern about the potential ‘cocktail effects’ of using these chemicals in combination.

What is the Commission’s current thinking in this area and what research has it commissioned to assess the dangers?

 OJ C 237, 22/07/2014
Last updated: 3 December 2013Legal notice